CLRB
Cellectar BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
CLRB vs peer average
78/100
CLRB vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 2 · D 3 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
TPST is the first available peer comparator.
Tempest Therapeutics is a small-cap oncology development company with clinical-event sensitivity similar to CLRB. It is a useful sentiment peer for binary data and financing risk, though it is not a radiopharma peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CLRB
Cellectar Biosciences
TPST
Tempest Therapeutics
Grade
B
B
Momentum
69
85
Value
41
41
Sentiment
63
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs TPST
CLRB / TPST
Grade Position
Above peers
CLRB vs. peer average (B vs. D)
78/100
Momentum
69
TPSTValue
41
CLRBSentiment
63
CLRBRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CLRB
TPST is the first peer returned for this comparison set.